Pharmaceutial & Healthcare

 The global polycystic ovarian syndrome (PCOS) treatment market size is expected to value at USD 5.1 billion by 2025. The market is subject to witness a substantial growth due to the easy identification of symptoms associated with this syndrome, and easy accessibility to a range of drug essential for the treatment. Furthermore, substantial focus on the development of the drug to find permeant solution involving complete cure for the polycystic ovarian syndrome (PCOS) and rising investment by industry players for research development of drugs are some of the critical factors expected to fuel growth of the PCOS treatment market during the forecast period. Globally, the market is predicted to grow at CAGR of 5.0% in forecast period, providing numerous opportunity for market players to invest for research and development in the polycystic ovarian syndrome (PCOS) treatment market. Currently, no particular medication has been developed for treatment of PCOS treatment market. Thus, sympto...

 The global Xerostomia (Dry Mouth) Therapeutics Market is anticipated to reach USD 796.1 million and is anticipated to grow at a CAGR of 3.2% in the years to come. Xerostomia is a clinical condition of dry mouth and does not show the signs of hyposalivation and symptoms on frequent terms. This condition is observed when the rate of saliva flow is low in comparison with absorption across the oral mucosa coupled with rate of fluid evaporation from the mouth. Prolonged xerostomia is a significant disease in patients since it affects speech, chewing, denture-wearing, and swallowing activities. The defined causes of hyposalivation and xerostomia are the use of several medications such as antidepressants, anticoagulants, antiretroviral, hypoglycemics, multivitamins and supplements, and anti-inflammatory drugs. Prevalence of xerostomia persists in a large population with different age groups despite following medical or dental consultation. Rise in use of prescribed medication coupled wit...

 The global Hemoglobinopathies Market size is expected to value at USD 8.82 billion by 2022. The hemoglobinopathies industry is subject to witness a substantial growth due to the growing prevalence of hemoglobinopathies, particularly in underdeveloped economies such as South East Asia, Middle East region, and Africa. In addition, increasing number of high unmet needs for diagnosis and treatment of these disorders is expected to fuel the growth of hemoglobinopathies market over the next seven years. Globally, the hemoglobinopathies industry is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the market. Hemoglobinopathy is commonly known as a genetic defect, which results in abnormal structure of single globin chains of the hemoglobin molecule. Hemoglobinopathies are hereditary or inherited single gene disorders. The hemoglobinopathies are also referred as autosomal co-dominant trai...

 The global Botulinum Toxin Market size is expected to value at USD 7.3 billion by 2025. The market is subject to witness a substantial growth due to the ever-growing population and rising number of minimally invasive or non-invasive procedures performed each year. Botulinum toxin is commonly used as a neurotoxin, which is typically found in various antigenic forms namely BNT-A, BNT-B, BTT-C, BNT-D, BNT-E, BNT-F and BNT-G. These antigenic forms are produced with the help of an anaerobic bacterium, Clostridium botulinum. Common application of the botulinum toxin is the aesthetic therapy. Hence, these factors are expected to play vital for sustained market growth in the upcoming years. Globally, the botulinum toxin industry is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the market of botulinum toxin. However, use of botulinum toxin has severe side effects such as allergic reacti...

 The global Cartilage Repair/Regeneration Market size is expected to value at USD 6.7 billion by 2025. The market is subject to witness a substantial growth due to the increasing occurrence of bone and joint related diseases such as Osteoarthritis (OA) and arthritis, and recent technological advancements in cartilage regeneration. Growing geriatric population in across the globe, is susceptible towards Osteoarthritis (OA) and arthritis due to weakened bone structure. This in return is expected to fuel the growth of cartilage repair/regeneration industry over the forecast period. Additionally, change in food patterns leading to obesity is considered as one of the prominent factor associated with market growth, in the recent years. Globally, the cartilage repair/regeneration market is predicted to grow at CAGR of 5.4% in forecast period, providing numerous opportunities for market players to invest in research and development in the market. Growing prevalence of diabetes is considere...

 The global Joint Reconstruction Devices Market size is expected to value at USD 30.4 billion by 2025. The market is subject to witness a substantial growth due to the increasing adoption of minimally invasive surgeries and recent technological advancement in the healthcare sector. Factors such as modernization of surgical devices and procedures coupled with increase in the health expenditure by local governments from developed economies across the globe are expected to amplify the growth of the market, in recent years. Globally, the joint reconstruction devices market is predicted to grow at CAGR of 4.9% in forecast period, providing numerous opportunities for market players to invest in research and development in the market. Additionally, the rise in demand for minimally invasive diagnostic, innovative surgical methodologies, increase in occurrence of orthopedic conditions, and a large patient pool are some of the critical factors attributing to the growth of joint reconstructio...

 Global Live Cell Imaging Market is estimated to reach USD 9.0 billion by 2025 owing to the increasing popularity of kinetic research over fixed cellular analysis. Live cell imaging is the study of cells in real-time with the help of images obtained from microscopes and screening systems. Technology has enhanced the approach of scientists to examine proteins, internal cell structures molecular synergy and cellular processes. This allows them to observe cells and to understand the in-depth analysis instead of learning the images of fixed cells. More information that is precise can be achieved with the help of live cell imaging that plays an important role in understanding cell dynamics in research fields like immunology, microbiology, neurology and others. Technological modernizations in live cell imaging are projected to fulfill the demands of different end-users. Technological improvements along with other factors are likely to boost the live cell imaging market in the forecast pe...